Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nadolol for Proliferating Infantile Hemangiomas

This study has been completed.
Information provided by (Responsible Party):
Elena Pope, The Hospital for Sick Children Identifier:
First received: November 8, 2009
Last updated: August 1, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)